Medicine & TechnologyThe health care workers to receive the coronavirus vaccine are having their second doses. The vaccine's second dose is more likely to cause side effects.
An additional mutation in the coronavirus spike protein may help it elude the detection of antibodies. Scientists are researching more about the British and African COVID-19 strain.
In this report, the researchers performed an in-depth analysis of brain tissue samples from 19 patients who died between March and July 2020 after undergoing Covid-19.
Experts clarified why Covaxin has been given the nod for restricted emergency use. They advise against Covaxin, saying that there is no proof of its efficacy.
Despite being more contagious than the first coronavirus variant, the new COVID-19 strain does not cause more severe illness or a higher death rate according to a major study.
Experts are studying the possibility of giving instant long-term immunity to high-risk COVID-19 patients using AstraZeneca's vaccine. Is AstraZeneca winning?